MRC to receive over USD200m

The Medical Research Council is to receive over US$200m as part of one of the biggest deals to come out of breakthroughs by British scientists. It involves a drug created using patented technology derived from research at the MRC Laboratory of Molecular Biology in Cambridge and The Scripps Research Institute in California.